Mechanisms of action of cholecystokinin in the canine gastrointestinal tract: Role of vasoactive intestinal peptide and nitric oxide

Journal of Pharmacology and Experimental Therapeutics

Volumn 279, Issue 1, 1996, Pages 306-316

  Vergara, P ^a,b   Woskowska, Z ^a   Cipris, S ^a   Fox Threlkeld, J E T ^a   Daniel, E E ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; 1 [2,3 DIHYDRO 1 (2' METHYLPHENACYL) 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL] 3 (3 METHYLPHENYL)UREA; ATROPINE; CHOLECYSTOKININ; CHOLECYSTOKININ RECEPTOR; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; DEVAZEPIDE; GASTRIN RECEPTOR; NITRIC OXIDE; RECEPTOR SUBTYPE; TETRODOTOXIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; INTESTINE CONTRACTION; INTESTINE MOTILITY; INTRAARTERIAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; STOMACH ANTRUM; TACHYPHYLAXIS;

ANIMALS; BENZODIAZEPINES; CHOLECYSTOKININ; DOGS; FEMALE; GASTROINTESTINAL MOTILITY; HEXAMETHONIUM; MALE; MUSCLE CONTRACTION; NITRIC OXIDE; PERFUSION; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0030431327     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. ALLESCHER, H.-D., BEREZIN, I., JURY, J. AND DANIEL, E. E.: Characteristics of canine lower esophageal sphincter: A new electrophysiological tool. Am. J. Physiol. 255: G441-G453, 1988.
2. ALLESCHER, H. D., DANIEL, E. E., FOX, J. E. T., KOSTOLANSKA, F. AND ROVATI, L. A.: Effect of the novel cholecystokinin receptor antagonist CR-1392 on cholecystokinin-induced antroduodenal and pyloric motor activity in vivo. J. Pharmacol. Exp. Ther. 251: 1134-1141, 1989.
3. BEINBORN, M., LEE, Y. M., MCBRIDE, E. E., QUINN, S. S. AND KOPIN, A. S.: A single amino acid of the cholecystokinin-B/gastrin receptor determines specificity for non-peptide antagonists. Nature (Lond.) 362: 348-350, 1993 [Erratum: Nature (Lond.) 364: 362, 1994].
4. BEREZIN, I., SNYDER, S. H., BREDT, D. S. AND DANIEL, E. E.: Ultrastructural localization of nitric oxide synthase in canine small intestine and colon. Am. J. Physiol. 266: C981-C989, 1994.
5. B/ gastrin receptors coupled to contraction in guinea-pig stomach muscle. Br. J. Pharmacol. 114: 339-348, 1995.
6. BOYLE, S. J., TANG, K. W., WOODRUFF, G. N. AND MCKNIGHT, A. T.: Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide. Br. J. Pharmacol. 109: 913-917, 1993.
7. BUENO, L. AND FERRE, J. P.: Central regulation of intestinal motility by somatostatin and cholecystokinin octapeptide. Science (Wash. DC) 216: 1427-1429, 1982.
8. CHRISTINCK, F., JURY, J., CAYABYAB, F. AND DANIEL, E. E.: Nitric oxide may be the final mediator of non-adrenergic non-cholinergic inhibitory junction potentials in gut. Can. J. Physiol. Pharmacol. 69: 1448-1458, 1991.
9. CORWIN, R. L. AND SMITH, G. P.: Different effects of CCK antagonists on gastric-acid response to CCK and pentagastrin. Peptides 14: 253-257, 1993.
10. DAL FORNO, G., PIETRA, C., URCIUOLI, M., VAN AMSTERDAM, F. T. M., TOSON, G., GAVIRAGHI, G. AND TRIST, D.: Evidence for two cholecystokinin receptors mediating the contraction of the guinea pig isolated ileum longitudinal muscle myenteric plexus. J. Pharmacol. Exp. Ther. 261: 1056-1063, 1992.
11. DANIEL, E. E., COSTA, M., FURNESS, J. B. AND KEAST, J. R.: Peptide neurons in the canine small intestine. J. Comp. Neurol. 237: 227-238, 1985.
12. DANIEL, E. E. AND FOX -THRELKELD, J. E. T.: VIP release from small intestinal neurons: Its modulation by multiple neuropeptides: Association with motility changes and functional role. Biomed. Res. 13: 195-200, 1992.
13. DANIEL, E. E., HAUGH, C., WOSKOWSKA, Z., CIPRIS, S., JURY, J. AND FOX-THRELKELD, J. E. T.: Role of NO-related inhibition in intestinal function: Relation to vasoactive intestinal polypeptide (VIP). Am. J. Physiol. 266: G31-G39, 1994.
14. DANIEL, E. E. AND KOSTOLANSKA, F.: Functional studies of nerve projections in the canine intestine. Can. J. Physiol. Pharmacol. 67: 1074-1085, 1989.
15. DELVALLE, J., CHIBA, T., PARK, J. AND YAMADA, T.: Distinct receptors for cholecystokinin and gastrin in canine fundic D-cells. Am. J. Physiol. 264: G811-G815, 1993.
16. FARGEAS, M. J., BASSOTI, G., FIORAMONTI, J. AND BUENO, L.: Involvement of different mechanisms in the stimulatory effects of cholecystokinin octapeptide on gastrointestinal and colonic motility in dogs. Can. J. Physiol. Pharmacol. 67: 1205-1212, 1989.
17. FOURMY, D., ZAHIDI, A., PRADAYROL, L., VAYSSETTE, J. AND RIBET, A.: Relationship of CCK/gastrin receptor binding to amylase release in dog pancreatic acini. Regul. Pept. 10: 57-68, 1984.
18. FOX, J. E. T. AND DANIEL, E. E.: Substance P: A potent inhibitor of the canine small intestine in vivo. Am. J. Physiol. 250: G21-G26, 1986.
19. FOX, J. E. T., DANIEL, E. E., JURY, J., FOX, A. E. AND COLLINS, S. M.: Sites and mechanisms of action of neuropeptides on canine gastric motility differ in vivo and in vitro. Life Sci. 33: 817-825, 1983.
20. FOX-THRELKELD, J. E. T., DANIEL, E. E., CHRISTINCK, F., HRUBY, V. J., CIPRIS, S. AND WOSKOWSKA, Z.: Identification of mechanisms and sites of actions of mu and delta opioid receptor activation in the canine intestine. J. Pharmacol. Exp. Ther. 268: 689-700, 1994.
21. FOX-THRELKELD, J. E. T., DANIEL, E. E., CHRISTINCK, C., WOSKOWSKA, Z., CIPRIS, S. AND MCDONALD, T. J.: Peptide YY stimulates circular muscle contractions of the isolated perfused canine ileum by inhibiting nitric oxide release and enhancing acetylcholine release. Peptides 14: 1171-1178, 1993.
22. FOX-THRELKELD, J. E. T., MANAKA, H., MANAKA, Y., CIPRIS, S. AND DANIEL, E. E.: Stimulation of circular muscle motility of the isolated perfused canine ileum: Relationship to VIP output. Peptides 12: 1039-1045, 1991.
23. GIULIANI, S., LIPPE, I. T., MAGGI, C. A. AND MELI, A.: Dual effects of cholecystokinin-octapeptide on duodenal motility of urethane-anesthetized rats. J. Pharmacol. Exp. Ther. 252: 1312-1317, 1990.
24. GRIDER, J. R. AND MAKHLOUF, G. M.: Regional and cellular heterogeneity of cholecystokinin receptors mediating muscle contraction in the gut. Gastroenterology 92: 175-180, 1987.
25. GRIDER, J. R. AND MAKHLOUF, G. M.: Distinct receptors for cholecystokinin and gastrin on muscle cells of stomach and gallbladder. Am. J. Physiol. 259: G184-G190, 1990.
26. A receptors. Eur. J. Pharmacol. 209: 263-266, 1991.
27. HUANG, S. C., YU, D. H., WANK, S. A., MANTEY, S., GARDNER, J. D. AND JENSEN, R. T.: Importance of sulfation of gastrin or cholecystokinin (CCK) on affinity for gastrin and CCK receptors. Peptides 10: 785-789, 1989.
28. HYRHORENKO, L. M., WOSKOWSKA, Z. AND FOX-THRELKELD, J. E. T.: Nitric oxide (NO) inhibits release of acetylcholine from nerves of isolated circular muscle of the canine ileum: Relationship to motility and release of nitric oxide. J. Pharmacol. Exp. Ther. 271: 918-926, 1994.
29. JENSEN, R. T. AND GARDNER, J. D.: Cholecystokinin receptor antagonists in vitro. In Cholecystokinin Antagonists in Gastroenterology, ed. by G. Addler and C. Beglinger, pp. 93-111, Spring-Verlag, Berlin, 1991.
30. KANTOH, M., TAKAHASHI, T., KUSUNOKI, M., YAMAMURA, T. AND UTSUNOMIYA, J.: Dual action of cholecystokinin-octapeptide on the guinea pig antrum. Gastroenterology 92: 376-382, 1987.
31. KELLOW, J. E., MILLER, L. J., PHILLIPS, S. F., HADDAD, A. C., ZINSMEISTER, A. R. AND CHARBONEAU, J. W.: Sensitivities of human jejunum, ileum, proximal colon, and gallbladder to cholecystokinin octapeptide. Am. J. Physiol. 252: G345-G356, 1987.
32. KOPIN, A. S., LEE, Y. M., MCBRIDE, E. W., MILLER, L. J., LU, M., LIN, H. Y., KOLAKOWSKI, L. F., JR. AND BEINBORN, M.: Expression cloning and characterization of the canine parietal cell gastrin receptor. Proc. Natl. Acad. Sci. U.S.A. 89: 3605-3609, 1992.
33. KOSTKA, P., JANG, E., WATSON, E. G., STEWART, J. AND DANIEL, E. E.: Nitric oxide synthase in the autonomic nervous system of canine ileum. J. Pharmacol. Exp. Ther. 264: 234-239, 1993.
34. LUCAITES, V. L., MENDOLSOHN, L. G., MASON, N. R. AND COHEN, M. L.: CCK-8, CCK-4 and gastrin-induced contractions in guinea pig ileum: Evidence for differential release of acetylcholine and substance P by CCK-A and CCK-B receptors. J. Pharmacol. Exp. Ther. 256: 695-703, 1991.
35. MANAKA, H., MANAKA, Y., KOSTOLANSKA, F., FOX, J. E. T. AND DANIEL, E. E.: Release of VIP and substance P from isolated perfused canine ileum. Am. J. Physiol. 257: G182-G190, 1989.
36. MANTYH, C. R., PAPPAS, T. N. AND VIGNA, S. R.: Localization of cholecystokinin A and cholecystokinin B/gastrin receptors in the canine upper gastrointestinal tract. Gastroenterology 107: 1019-1031, 1994.
37. MAO, Y. K., BARNETT, W., COY, D. H., TOUGAS, G. AND DANIEL, E. E.: Distribution of vasoactive intestinal polypeptide (VIP)-binding in circular muscle and characterization of VIP-binding in canine small intestinal mucosa. J. Pharmacol. Exp. Ther. 258: 986-991, 1991.
38. MAO, Y. K., TOUGAS, G., BARNETT, W. AND DANIEL, E. E.: VIP receptors on canine submucosal synaptosomes. Peptides 14: 1149-1152, 1993a.
39. MAO, Y. K., WANG, Y. F. AND DANIEL, E. E.: Distribution and characterization of vasoactive intestinal polypeptide (VIP) binding in canine lower esophageal sphincter. Gastroenterology 105: 1370-1377, 1993b.
40. MAO, Y. K., WANG, Y. F. AND DANIEL, E. E.: Characterization of cholecystokinin receptors in canine intestinal circular muscle. Peptides 16: 1025-1029, 1995.
41. MARTINEZ, V., JIMENEZ, M., GONALONS, E. AND VERGARA, P.: Mechanism of action of CCK in avian gastroduodenal motility: Evidence for nitric oxide involvement. Am. J. Physiol. 265: G842-G850, 1993.
42. MORAN, T. H., KORNBLUH, R., MOORE, K. AND SCHWARTZ, G. J.: Cholecystokinin inhibits gastric emptying and contracts the pyloric sphincter in rats by interacting with low affinity CCK receptor. Regul. Pept. 52: 165-172, 1994.
43. MUKHOPADHYAY, A. K., THOR, P. J., COPELAND, E. M., JOHNSON, L. R. AND WEISBRODT, N. W.: Effect of cholecystokinin on myoelectric activity of small bowel of the dog. Am. J. Physiol. 232: E44-E47, 1977.
44. NIEDERAU, C. AND KARAUS, M.: Effects of CCK-receptor blockade on intestinal motor activity in conscious dogs. Am. J. Physiol. 260: G315-G324, 1991.
45. NISHIDA, A., MIYATA, K., TSUTSUMI, R., YUKI, H., AKUZAWA, S., KOBAYASHI, A., KAMATO, T., ITO, H., YAMANO, M., KATUYAMA, Y., SATOH, M., OHTA, M. AND HONDA, K.: Pharmacological profile of (R)-1-[2,3-dihydro-1-(2′-methylphenacyl)-2-oxo-5-phenyl-l1H-1,4- benzodiazepin-3-yl]-3-(3-methylphenyl)-urea (YMO22), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo. J. Pharmacol. Exp. Ther. 269: 725-731, 1994.
46. PATEL, M. AND SPRAGGS, C. F.: Functional comparisons of gastrin/cholecystokinin receptors in isolated preparations of gastric mucosa and ileum. Br. J. Pharmacol. 106: 275-282, 1992.
47. RAYBOULD, H. E.: Capsaicin-sensitive vagal afferents and CCK in inhibition of gastric motor function induced by intestinal nutrients. Peptides 12: 1279-1283, 1991.
48. RAYBOULD, H. E., ZITTEL, T. T., HOLZER, H. H., KENT LLOYD, K. C. AND MEYER, J. H.: Gastroduodenal sensory mechanisms and CCK in inhibition of gastric emptying in response to a meal. Dig. Dis. Sci. 39: 41S-43S, 1994.
49. REHFELD, J. F.: Cholecystokinin. In Handbook of Physiology. Gastrointestinal System, Vol. 2, Neural and Endocrine Physiology, ed. by S. T. Schultz, G. M. Makhlouf and B. B. Rauner, pp. 337-358, American Physiological Society, Bethesda, MD, 1989.
50. RODRIGUEZ-MEMBRILLA, A., MARTINEZ, V., JIMENEZ, M. AND VERGARA, P.: Is nitric oxide the final mediator regulating the migrating myoelectric complex? Am. J. Physiol. 268: G207-G214, 1995a.
51. RODRIGUEZ-MEMBRILLA, A., MARTINEZ, V. AND VERGARA, P.: Peripheral and central CCK receptors regulate postprandial intestinal motility in the rat. J. Pharmacol. Exp. Ther., in press, 1995b.
52. SILVENTE-POIROT, G.: The peripheral cholecystokinin receptors. Eur. J. Biochem. 215: 513-529, 1993.
53. STEWART, J. J. AND BURKS, T. F.: Actions of cholecystokinin octapeptide on smooth muscle of isolated dog intestine. Am. J. Physiol. 232: E306-E310, 1977.
54. VERGARA, P., WOSKOWSKA, Z., CIPRIS, S., FOX-THRELKELD, J. E. T. AND DANIEL, E. E.: Somatostatin excites canine ileum ex vivo: Role for NO? Am. J. Physiol. 269: G12-G21, 1995.
55. VIZI, S. E., BERTACCINI, G., IMPICCIATORE, M. AND KNOLI, J.: Evidence that acetylcholine released by gastrin and related polypeptides contributes to their effect on gastrointestinal motility. Gastroenterology 64: 268-277, 1973.
56. WINGATE, D. L., THOMPSON, H. H., PEARCE, E. A. AND DAND, A.: The effects of exogenous cholecystokinin and pentagastrin on myoelectrical activity in the small intestine of the conscious fasted dog. In Proceedings of the Sixth International Symposium on Gastrointestinal Motility, ed. by J. H. L. Duthie, pp. 47-58, MTP Press, Lancaster, UK, 1978.